UBN1 inhibitors are a class of compounds with the unique ability to modulate the function of UBN1, a protein that plays a critical role in chromatin remodeling and gene expression. These inhibitors act primarily by influencing the chromatin structure and histone modifications, processes where UBN1 is significantly involved. They achieve this by affecting the acetylation and methylation of histones, key epigenetic marks that dictate chromatin configuration and gene accessibility. By altering these histone modifications, UBN1 inhibitors can impact the binding and function of UBN1 in the chromatin context, thereby influencing the gene expression patterns within cells. This influence extends to various cellular processes including DNA repair, cell cycle progression, and developmental pathways, reflecting the broad scope of UBN1's role in chromatin dynamics.
In addition to targeting histone modifications, UBN1 inhibitors also encompass compounds that affect the broader epigenetic landscape, including DNA methylation. By modulating DNA methylation patterns, these inhibitors can further influence the chromatin environment and thus UBN1's activity. This approach underscores the interconnected nature of epigenetic mechanisms and highlights the multifaceted strategies employed by UBN1 inhibitors to regulate chromatin structure and function. Furthermore, by impacting the chromatin dynamics, UBN1 inhibitors can indirectly affect the recruitment and assembly of chromatin-related complexes, including those involving UBN1. This indirect influence is pivotal in controlling the complex orchestration of gene regulation and cellular differentiation processes. The capacity of UBN1 inhibitors to modulate such fundamental aspects of cell biology underscores their significance in understanding and influencing the mechanisms of chromatin-based regulation and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by altering histone acetylation, could possibly inhibit UBN1's role in gene regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can affect DNA methylation, which could possibly inhibit UBN1's chromatin remodeling activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid can modify chromatin structure, which could possibly inhibit UBN1's function in gene expression. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966, by influencing chromatin acetylation, could possibly inhibit UBN1's function. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat could possibly inhibit UBN1 by altering chromatin dynamics. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, affecting chromatin structure, could possibly inhibit UBN1's role in gene expression and DNA repair. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 could possibly inhibit UBN1 by altering chromatin conformation. | ||||||